Alzheimer’s Disease and Related Dementias

ADRD Training

MAGEC is committed to providing interprofessional educational sessions on Alzheimer’s Disease and Related Dementias (ADRD) for healthcare professionals who serve the elderly community. On this page you will find a diverse menu of video educational sessions on ADRD that you can access at no cost. Please see the list of available videos and click on the provided link.

The videos displayed in this page can’t be viewed on mobile devices such as tablets or mobile phones. You must use a desktop or laptop with a compatible video player. If you have problems accessing the videos listed below, you can download a free version of Microsoft Silverlight at http://www.microsoft.com/silverlight/

MAGEC is a project supported by funds from the Bureau of Health Professions (BHPr), Health Resources and Services Administration (HRSA), Department of Health and Human Services (DHHS). Geriatric Education Centers under Grant Number UB4HP19066.

This information or content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by the BHPr, HRSA, DHHS, U.S. Government or MAGEC.

Alzheimer’s Disease — Review and Update

This presentation provides an overview of the diagnosis, clinical presentation, prevalence, risk factors, course/ progression and management of Major Neurocognitive disorder due to Alzheimer’s disease. Major Neurocognitive disorder due to Alzheimer’s disease is the most common type of Major Neurocognitive disorder. In primary care settings fewer than 50% of patients with Major Neurocognitive disorder are diagnosed and only half of them are treated with currently approved therapies.

Presenter: Adriana Cortes, MD.

Click Here to View this Educational Session

Managing Behavioral Problems in Patients with Dementia

In this presentation, the primary care provider will learn which is his /her role in managing behavioral issues of patients with dementia at home. The primary care provider will learn how to recommend the use of non-pharmacologic approaches to the caregiver Issues including driving in the elderly and deciding when to place their family members at a nursing home will be discussed.

Presenters:Samir Sabbag M.D.

Click Here to View this Educational Session

DSM-5 Course Session l

This presentation provides an overview of the structural changes of the Diagnostic and Statistical Manual of Mental Disorders DSM-5. Dr. Sabbag offers an introduction to the use of DSM-5 and highlights the most prominent changes in the manual. He discusses significant alterations in the criteria not included in previous manuals and changes in terminology of clinical relevance. This educational webcast is delivered in two sessions of 60 minutes each. (The DSM-5 Course Session II will be provided in April, 2014).

Presenters:Samir Sabbag M.D.

Click Here to View this Educational Session

Update and Review of the Pharmacological Treatment of Alzheimer’s Disease

This presentation focuses on management and interventions in dementia. It describes positive and negative expectations and outcomes of pharmaceutical agents approved to manage dementia will be outlined. Behavioral and psychological problems that commonly co-occur with dementia will be described, and the pharmacological management of such disturbed behaviors (e.g., psychosis, agitation, sleep disturbance, depression) and other secondary complications in dementia will be discussed. The presenter identifies and describes the mechanisms of action, dosing and common adverse effects of three cholinerterase inhibitors; donepezil, rivastigmine, and galantamine, and the NMDA receptor antagonist memantine. The presenter also discusses the negative impact that other medications may have in the elderly population with dementia.

Presenters: Jose A. Rey, MS. Pharm.D BCPP

Click Here to View this Educational Session

Biomarkers and the Complex Diagnosis of Alzheimer’s Disease: Amyloid – PET Imaging in Clinical Practice

Presenters: Ran Jan Duara M.D, Adam S. Fleisher, M.D, M.A.S

This activity is designed to meet the educational needs of neurologists, imaging technologists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer’s Disease.

This presentation, discusses how evidence-based guidelines for AD diagnosis can be incorporated into neurology practice and the current use of AD biomarkers. It reviews the clinical data regarding brain imaging in AD including amyloid-PET imaging for the detection of cortical fibrillary amyloid in patients with cognitive impairment. This presentation also assess the importance of diagnosis in AD and the challenges encountered and applies the criteria for appropriate use of amyloid-PET as recommended in a recent report from AITF, SNMM and AA. Additionally, it discusses how the use of biomarkers will optimize clinical trials design and guide therapeutic decisions in clinical practice in the context of emerging therapies

Click Here to view this educational session

Dementia: Issues in Assessment

Presenter: Debra Lacey, PhD, LCSW

This presentation provides information relevant to assessment of dementia in older adults. This includes differentiating between “reversible” and “irreversible dementias. Assessment approaches focusing on functional behaviors are also presented.

This session provides information to: 1) differentiate between reversible and irreversible causes of cognitive impairment in older adults; 2) recognize how brain impairment in Alzheimer’s Disease and Related Disorders (ADRD) manifests in “problem behaviors”; and 3) recognize how to “stage” ADRD disease progression through functional assessments.

Click Here to View this Educational Session

Click Here to see the power point slides

Dementia: Interventions for Older Adults with Dementia and their Caregivers

Presenter: Debra Lacey, PhD, LCSW

This educational session provides information relevant to assessment of dementia in older adults by focusing on interventions, including evidence-based interventions. Participants will learn how to match interventions with assessments of functional impairment. Social work roles in providing psychosocial education and support to caregivers will be woven throughout the session.

Click Here to View this Educational Session

Click Here to see the power point slides

Alzheimer’s Disease: State of the Science- Evaluation and Treatment

Presenter: Marc E. Agronin, M.D.

This presentation discusses the latest developments in Alzheimer’s disease. It describes the new staging, the use of biomarkers and new imaging techniques. The presenter reviews how current theories are shaping the pipeline of experimental agents. Additionally, the presentation provides a review of current definitions and staging for Alzheimer’s disease, reviews new diagnostics and current treatments and discusses experimental approaches on the horizon.

Click Here to View this Educational Session

Differential Diagnosis of Neurocognitive Disorders

Presenter: María Llorente, M.D.

This presentation reviews the most commonly encountered neurocognitive disorders, their presenting symptoms, pathophysiology and features, including course and genetics. Age is the most common risk factor for neurocognitive disorders. By 2045 average life expectancy will be 80 and the number of individuals with dementia will exceed 15 million. There are insufficient geriatrics trained clinicians to provide care for all these persons such that all clinicians are likely to encounter patients with dementia and/or their caregivers in various clinical settings.

Click Here to View this Educational Session (508 Compliant)

Click Here to View this Educational Session

Click Here to see the powerpoint Slides

Evacuate or Shelter in Place? Hurricanes, Long-Term Care, and Providing for People with Alzheimer’s Disease

Presenter: Janelle J. Christensen, Ph.D., M.P.H., M.A.

Deciding whether a facility should shelter in place or evacuate their residents to another location is a difficult decision as both options carry risks. This training covers best practices for health care professionals assisting people with Alzheimer’s Disease and Related Dementias ADRD during and after disasters, such as hurricanes. This Educational session provides an overview of research on long-term care during hurricanes, and covers Federal and state (Florida) regulations, with special attention to the needs of people with ADRD.

Click Here to View this Educational Session

Click Here to see the powerpoint Slides part 1

Click Here to see the powerpoint Slides part 2

Mental Health Consequences of Disasters Among Older Adults

Presenter: María Llorente, M.D.

This educational session allows the participants to: 1) recognize the unique vulnerabilities of older adults to adverse consequences of disasters; 2) identify the factors that increase the risk of developing a mental health consequence of disaster exposure; and 3) provide effective disaster preparedness for older adults.

The elderly are a vulnerable population disproportionately affected by natural disasters. To effectively recognize and treat mental health sequel of disasters in older adults, knowledge of individual history along with the cultural and historical context in which the individual has spent their life should be incorporated into the evaluation and management process. Symptoms and expression of disaster-related conditions including PTSD are influenced by specific trauma, age, race and ethnicity, psychosocial variants, along with proximity, rate, and amount of trauma exposure.

Click Here to View this Educational Session

Click Here to see the power point slides (part1)

Click Here to see the power point slides (part2)

Dangers & Dementia: Best Practices for Caregivers for people with ADRD during Hurricanes

Presenter: Janelle J. Christensen, Ph.D., M.P.H., M.A.

Deciding whether to evacuate or shelter in place for a hurricane can be a challenge for both formal and informal caregivers. This presentation covers disaster preparedness and response considerations for people caring for someone with Alzheimer’s Disease and Related Dementias (ADRD). Safety and best practices are presented for both evacuating and sheltering a long-term care facility. Suggestions for nurses working with community-dwelling families are also provided.
This educational session will help the program participants to: 1) Identify the costs and benefits of nursing home evacuation versus sheltering in place during a hurricane; 2) Identify unique concerns for caring for someone with ADRD during disasters (in the community, at home, and in a new facility); and cover regulations and best practices for staff and resident safety when evacuating and sheltering in place during a storm.

Click Here to View this Educational Session

Click Here to see the power point slides

Informal Care Giving For People with Alzheimer ’s Disease and Related Dementias: Reducing Common Risks

Presenter: Janelle J. Christensen, Ph.D., M.P.H., M.A.

This session address the needs of families affected by ADRD living in the community. The presenter gives a brief introduction to the trajectory of the disease and the best practices for staying safe in the home. Risks, such as the person with ADRD leaving the home unaccompanied by a caregiver and becoming lost, are discussed and safety measures are presented

Click Here to View this Educational Session

Click Here to see the power point slides

Danger, Dementia, and Disaster: Suggestions for informal caregivers providing care for someone with ADRD before, during, and after a Hurricane

Presenter: Janelle J. Christensen, Ph.D., M.P.H., M.A.

This educational session provides an introduction to the trajectory of Alzheimer’s disease and related disorders and how it can impact care during hurricanes. The presenter discusses risk reduction strategies, for both the caregiver and the person with ADRD, before, during, and after a hurricane.

Click Here to View this Educational Session

Click Here to see the power point slides

Management of Behavioral disturbances in dementia

Presenter: María Llorente, M.D.

This presentation reviews pharmacologic strategies that can be used as second line treatments when behavioral interventions have failed or when aggressive behavior is dangerous to others.
Behavioral disturbances in dementia are highly prevalent, and can occur in more than 75% of patients. These disturbances also cause significant burden and distress for caregivers. There are several behavioral strategies that can be used to address many of these behaviors and aid in delay of institutionalization.

Click Here to View this Educational Session

Click Here to see the power point slides

Managing Delirium in Acute Care

Presenters: Candice Hickman, MSN, RN
Lynn Coopersmith, BSN, RN, OCN

This educational session discusses the journey one hospital took to implement a program to help reduce the effects of delirium in the acute care setting. The presenters explain the impact of delirium in hospitalized patients and what the literature states as best practice in caring for these patients. A creative model of blending the Hospital Elder Life Program with caring philosophy and use of caring behaviors is the foundation of the program. The successes and opportunities of the program thus far are discussed. Specific case studies of actual patients at the hospital are shared.

Click Here to View this Educational Session

Click Here to see the power point slides

Memory Disorders: Evaluation and Diagnostic Process

Presenters: Elizabeth Crocco, MD
Gloria Peruyera, MS
M. Carolina Mendoza-Puccini, IMG, CCRC

This is an educational series of 5 sessions that provides an overview of signs and symptoms of dementia. This webcast highlights the importance of a complete medical evaluation, conducted by physicians and other health care professionals with specialized training and experience with memory and cognitive problems. It provides the various medical examinations and procedures involved in arriving at a diagnosis of Alzheimer’s disease or related dementia.

Video 1: Memory Disorder: Evaluation and Diagnostic Process
Video 2: Memory Disorder: Evaluation and Diagnostic Process – Interview caregiver
Video 3: Memory Disorder: Evaluation and Diagnostic Process Interview caregiver 2
Video 4: Memory Disorder: Evaluation and Diagnostic Process-Clinical Evaluation
Video 5: Memory Disorder: Evaluation and Diagnostic Process-Scales
Click Here for Video 1
Click Here for Video 2
Click Here for Video 3
Click Here for Video 4
Click Here for Video 5

PDF presentations

Memory Disorders: Evaluation and Diagnostic Process
Memory Disorders: Evaluation and Diagnostic Process-The steps
Memory Disorders: Evaluation and Diagnostic Process-The Barthel Index test
Memory Disorders: Evaluation and Diagnostic Process-NACC Uniform Data Set
Memory Disorders: Evaluation and Diagnostic Process-MOCA test
Memory Disorders: Evaluation and Diagnostic Process-Clinical Evaluation
Memory Disorders: Evaluation and Diagnostic Process-Scales

Neurocognitive Disorders: New DSM 5 Nomenclature

Presenter: María Llorente, M.D.

This presentation provide an update on the new diagnostic nomenclature for neurocognitive disorders in the DSM-V. This webcast will include an interactive component in which actual cases will be provided to participants who will then be asked to provide the diagnosis. The population of the United States is aging and with adults aged 65 and older expected to grow to 72 million by 2030. A recent meta-analysis indicated that the incidence of dementia rises exponentially to age 90, such that by 2050, 100 million people will be affected worldwide. At this same time of pending growth in demand for evaluation and management recommendations, the geriatric healthcare workforce is in very short supply. As a result, these patients will likely be seen in general healthcare provider offices and clinical settings.

Click Here to see the powerpoint slides
Click Here to see view this session

Alzheimer’s Disease: State of the Science- Evaluation and Treatment

Presenter: Marc E. Agronin, M.D.

This presentation discusses the latest developments in Alzheimer’s disease. It describes the new staging, the use of biomarkers and new imaging techniques. The presenter reviews how current theories are shaping the pipeline of experimental agents. Additionally, the presentation provides a review of current definitions and staging for Alzheimer’s disease, reviews new diagnostics and current treatments and discusses experimental approaches on the horizon.

Click Here to View this Educational Session

Sessions in Spanish

El centro de envejecimiento de la ciudad de Miami

Click Here to View this Educational Session

Presenter: Dra. Dolores Perdomo

El diagnostico temprano de la enfermedad de Alzheimer

Click Here to View this Educational Session

Presenter: Rosa E. Curiel Cid, Psy.D.

Manejo en Casa de problemas del Comportamiento en el adulto mayor con demencia

Click Here to View this Educational Session

Presenter: Sammir Sabbag M.D.

Alzheimer’s Association capitulo del sureste de la Florida 2014

Click Here to View this Educational Session

Presenter: Gloria Orlandi

Servicios de Cuidados Diurnos para Adultos-Centros Diurnos y Respiro

Click Here to View this Educational Session

Presenter: Angela Aracena

Planificacion del Futuro

Click Here to View this Educational Session

Presenter: Lourdes Corvo, Esq.

Manejo Farmacológico de la Demencia

Esta sesión educativa es en español.

Presentador: Daniel Varón

Esta sesión educativa provee información acerca de los tratamientos disponibles para pacientes con la enfermedad de Alzheimer. El presentador discute diferentes tratamientos para personas con desordenes cognitivos y de conducta. Los participantes podrán: 1) Identificar tratamientos específicos para pacientes con la enfermedad de Alzheimer; 2) Enumerar los medicamentos de primera línea usados para pacientes con la enfermedad de Alzheimer que presentan desordenes cognitivos y de conducta; 3) Entender los beneficios y posibles efectos secundarios de los medicamentos más usados para pacientes con demencia.

Presenter: Daniel Varon, MD

This lecture is designed to educate on the treatments currently available for patients diagnosed with Alzheimer’s Disease (AD). Treatments for both cognitive and behavioral disturbances are discussed during this session. The audience will be able to: 1) identify specific treatment targets in patients with AD; 2) list the medications which are used as first line options in the management of cognitive and behavioral disorders in patients with AD; and 3) understand the benefits and potential side effects of the medications most commonly used in dementia.

Haga clic aquí para ver esta sesión educativa

Haga clic aquí para ver las diapositivas en PowerPoint

Las Enfermedades Neurologicas Que Affectan a las Personas Mayores

Presentador: Clinton Wright, MD, MS

Esta sesión educativa es en español.

Esta sesión educativa provee información acerca de los desordenes neurológicos en adultos mayores, con énfasis en demencia y la pérdida de la capacidad cognoscitiva. El presentador describe: 1) Los tres tipos principales de la demencia; 2) Habilidades cognitivas afectadas por los tres tipos principales de la demencia; y 3) como las enfermedades vasculatorias contribuyen en los casos de demencia.

Presenter: Clinton Wright, MD, MS

This lecture discusses the neurological disorders in elderly people, with emphasis on cognitive decline and dementia. The presenter describes: 1) The three main types of dementia; 2) cognitive abilities affected by the main types of dementia, and 3) how vascular disease can contribute to dementia.

Haga clic aquí para ver esta sesión educativa
Haga clic aquí para ver las diapositivas en PowerPoint

Trastornos Neurocognitivos: Nueva Nomenclatura DSM5

Presentadora: Maria Llorente, MD

Esta presentación ofrece una actualización de la nueva nomenclatura de diagnóstico para trastornos neurocognitivos en el DSM-V. Este webcast incluye un componente interactivo en el que se proporcionarán casos reales a los participantes y luego se les pide que proporcionen el diagnóstico. La población de Estados Unidos está envejeciendo y con los adultos mayores de 65 años espera que crezca a 72 millones en 2030. Un análisis reciente indica que la incidencia de la demencia aumenta exponencialmente hasta los 90 años, de tal manera que para el año 2050, 100 millones de personas se verán afectadas en todo el mundo. A pesar de las expectativas de crecimiento en demanda de evaluaciones y de recomendaciones para el manejo de estos casos, la fuerza de trabajo para el cuidado de pacientes geriátricos es muy escasa. Como resultado, estos pacientes probablemente serán vistos en oficinas de proveedores de salud no especializados en este tipo de pacientes.

Haga clic aquí para ver esta sesión educativa
Haga clic aquí para ver las diapositivas en PowerPoint

Diagnóstico Diferencial de los Trastornos Neurocognitivos

Presentadora: María Llorente, M. D.
Esta presentación examina los trastornos neurocognitivos más comunes, sus síntomas, fisiopatología y características, incluyendo su curso y genética. La edad es el factor de riesgo más común para los trastornos neurocognitivos. En 2045 la esperanza de vida promedio será de 80 años y el número de personas con demencia superará los 15 millones. Se estima que no habrá suficientes médicos geriatras capacitados para atender a todas estas personas, de tal manera que todos los médicos podrán encontrar pacientes con demencia y/o a sus cuidadores en diferentes contextos clínicos.

Haga clic aquí para ver esta sesión educativa
Click Here to see the powerpoint Slides

Consecuencias de los desastres en salud mental de los adultos mayores

Presentadora: María Llorente, M. D.
Los ancianos son una población vulnerable desproporcionadamente afectada por los desastres naturales. Reconocer y tratar eficazmente secuela de la salud mental de los desastres en los adultos mayores, el conocimiento de la historia del individuo junto con el contexto cultural e histórico en el que el individuo ha pasado su vida debe ser incorporado en el proceso de evaluación y de gestión. Los síntomas y la expresión de las condiciones relacionadas con el desastre, incluyendo trastorno de estrés postraumático se ven influidos por el trauma específico, la edad, la raza y el origen étnico, las variantes psicosociales, junto con la proximidad, la frecuencia y la cantidad de exposición al trauma.

En esta sesión educativa permite a los participantes: 1) reconocer las vulnerabilidades específicas de los adultos mayores a las consecuencias adversas de los desastres, 2) identificar los factores que aumentan el riesgo de desarrollar un efecto sobre la salud mental de la exposición a los desastres, y 3) proporcionar una preparación eficaz en casos de desastre para los adultos mayores.

Haga clic aquí para ver esta sesión educativa
Click Here to see the powerpoint Slides